With facilities in the United States, Asia and Europe, Intricon designs, develops and manufactures miniature interventional, implantable and body-worn devices. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. The documents below detail our corporate governance framework and serve as the basis for our ongoing commitment to medical device innovation and our investors. Visit Investor Relations for more information and our most recent SEC Filings and press releases.

Corporate Governance Documents: